1Vigil-De GP, Montufar-Rueda C, Ruiz J. Expectant management of severe preeclampsia and preedampsia superimposed on chronic hypertension betwwen 24 and 34 weekspgestation, Eur J Obstet Gynecol Reprod Biol, 2003,107:24-27.
3Carlin A J, Farquharson RG, Quenby SM, et al. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin venus control. Hum Repro,2004,19 : 1211 -1 214.
7de Vries JI, van Pampus MG, Hague WM, et al. Low-mo- lecular- weight heparin added to aspirin in the prevention of recurrent early - onset pre - eclampsia in women with inherit- able thrombophilia., the FRUIT-RCT. J Thromb Haemost, 2012, 10: 64-72.
8Bujold E, Gouin K, Cx3t6 S. Low- molecular- weight hepa- tin added to aspirin in the prevention of recurrent early - onset pre- eclampsla in women with inheritable thrombophilia: the FRUIT-RCT: a rebuttal. J Thromb Haemost, 2012, 10: 1195.
9Harendra GG, Jayasekara RW, Dissanayake VH. Haplotypes of heparin- binding epidermal - growth- factor - like growth factor gene are associated with pre- eclampsia. J Obstet Gynaecol Res, 2012, 38: 239-246.
